A carregar...
Paricalcitol vs. cinacalcet for secondary hyperparathyroidism in chronic kidney disease: A meta-analysis
Paricalcitol and cinacalcet have been recommended to reduce parathyroid hormone (PTH) levels for patients with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD), and they are able to reduce the risk of hypercalcemia and hyperphosphatemia. However, to date, it has remained uncerta...
Na minha lista:
| Publicado no: | Exp Ther Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444362/ https://ncbi.nlm.nih.gov/pubmed/32855693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9044 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|